Nicholas Investments Partners »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 1.9M 1.13
2024-03-31 $2.2M 1.9M 1.17
2023-09-30 $2.1M 1.9M 1.12

More positions owned by Nicholas Investments Partners

Bwx Technologies (BWXT)
Ftai Aviation SHS (FTAI)
Embraer Sponsored Ads (ERJ)
Evercore Class A (EVR)
MGIC Investment (MTG)
Rev (REVG)
Monolithic Power Systems (MPWR)
Microsoft Corporation (MSFT)
Tfii Cn (TFII)
Transmedics Group (TMDX)
Western Alliance Bancorporation (WAL)
NVIDIA Corporation (NVDA)
Tanger Factory Outlet Centers (SKT)
Exxon Mobil Corporation (XOM)
Appfolio Com Cl A (APPF)

View all positions for Nicholas Investments Partners

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1